Cargando…

Dynamic 2-deoxy-2[18F] fluoro-D-glucose PET/MRI in human renal allotransplant patients undergoing acute kidney injury

Patients after solid organ kidney transplantation (KTX) often suffer from acute kidney injury (AKI). Parameters as serum creatinine indicate a loss of kidney function, although no distinction of the cause and prognosis can be made. Imaging tools measuring kidney function have not been widely in clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pajenda, Sahra, Rasul, Sazan, Hacker, Marcus, Wagner, Ludwig, Geist, Barbara Katharina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237443/ https://www.ncbi.nlm.nih.gov/pubmed/32427878 http://dx.doi.org/10.1038/s41598-020-65267-8

Ejemplares similares

Response evaluation of SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus using (18)F-FDG PET/MRI
por: Rasul, Sazan, et al.
Publicado: (2020)

[(18)F]2-Fluoro-2-deoxy-d-glucose PET/CT in mediastinal masses
por: Rankin, S.
Publicado: (2010)

2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease
por: Plöckinger, U., et al.
Publicado: (2018)

[(18)F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery
por: Rasul, Sazan, et al.
Publicado: (2018)

Optimal 2-[(18)F]fluoro-2-deoxy-d-galactose PET/CT protocol for detection of hepatocellular carcinoma
por: Horsager, Jacob, et al.
Publicado: (2016)

Accuracy of PET quantification in [(68)Ga]Ga-pentixafor PET/MR imaging of carotid plaques
por: Rausch, Ivo, et al.
Publicado: (2020)

Assessment of attenuation correction for myocardial PET imaging using combined PET/MRI
por: Lassen, Martin Lyngby, et al.
Publicado: (2017)

Kikuchi-Fujimoto disease mimicking malignant lymphoma with 2-[(18)F]fluoro-2-deoxy-D-glucose PET/CT in children
por: Kim, Ji Eun, et al.
Publicado: (2014)

Evidencing leprosy neuronal inflammation by 18-Fluoro-deoxy-glucose
por: Penna, Patricia Sola, et al.
Publicado: (2023)

A Simultaneous Multiparametric (18)F-FDG PET/MRI Radiomics Model for the Diagnosis of Triple Negative Breast Cancer
por: Romeo, Valeria, et al.
Publicado: (2022)

Radiotherapeutic use of 2-deoxy-2-[(18)F]fluoro-D-glucose – a comment
por: Meyer, Michael Andrew
Publicado: (2004)

Assessing the kidney function parameters glomerular filtration rate and effective renal plasma flow with dynamic FDG-PET/MRI in healthy subjects
por: Geist, Barbara K., et al.
Publicado: (2018)

Assessment of diffuse Lewy body disease by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET)
por: Mirzaei, Siroos, et al.
Publicado: (2003)

Metabolic liver function in humans measured by 2-(18)F-fluoro-2-deoxy-D-galactose PET/CT–reproducibility and clinical potential
por: Bak-Fredslund, Kirstine P., et al.
Publicado: (2017)

Assessment of the kidney function parameters split function, mean transit time, and outflow efficiency using dynamic FDG-PET/MRI in healthy subjects
por: Geist, Barbara K., et al.
Publicado: (2019)

Clinical Utility of (18)F-2-Fluoro-deoxy-d-glucose PET Imaging in Locally Advanced Esophageal/Gastroesophageal Junction Adenocarcinoma
por: Cowzer, Darren, et al.
Publicado: (2023)

Quantitative assessment of atherosclerotic plaques on (18)F-FDG PET/MRI: comparison with a PET/CT hybrid system
por: Li, Xiang, et al.
Publicado: (2016)

TMSOTf assisted synthesis of 2’-deoxy-2’-[(18)F]fluoro-β-D-arabinofuranosylcytosine ([(18)F]FAC)
por: Gangangari, Kishore K., et al.
Publicado: (2018)

Evaluation of (18)F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy
por: Shoda, H, et al.
Publicado: (2007)

Excretion of glucose analogue with SGLT2 affinity predicts response effectiveness to sodium glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus
por: Geist, Barbara Katharina, et al.
Publicado: (2023)

Added value of quantitative, multiparametric 18F-FDG PET/MRI in the locoregional staging of rectal cancer
por: Herold, Alexander, et al.
Publicado: (2022)

(18)F-fluoro-2-deoxy-D-glucose positron emission tomography findings of neurolymphomatosis
por: Jung, Yun Hwa, et al.
Publicado: (2014)

Erratum to: Quantitative assessment of atherosclerotic plaques on (18)F-FDG PET/MRI: comparison with a PET/CT hybrid system
por: Li, Xiang, et al.
Publicado: (2016)

Opportunities for 2-[(18)F] Fluoro-2-Deoxy-D-Glucose PET/CT in Cervical-Vaginal Neuroendocrine Carcinoma: Case Series and Literature Review
por: Lin, Yin, et al.
Publicado: (2012)

Is 2-deoxy-2-[(18)F]fluoro-D-glucose PET/CT acquisition from the upper thigh to the vertex of skull useful in oncological patients?
por: Salvatore, B., et al.
Publicado: (2014)

[(18)F]2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood-Brain Barrier Permeability Induced by Focused Ultrasound
por: Hugon, Gaëlle, et al.
Publicado: (2021)

Comparison of Positron Emission Tomography Using 2-[(18)F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[(18)F]-fluorothymidine in Lung Cancer Imaging
por: Wang, Fu-Li, et al.
Publicado: (2016)

Urinary neprilysin in the critically ill patient
por: Pajenda, Sahra, et al.
Publicado: (2017)

Prospective validation of 18F-Fluoroethylcholine as a tracer in PET/MRI for the evaluation of breast lesions and prediction of lymph node status
por: Clauser, Paola, et al.
Publicado: (2023)

Prognostic Significance of 2-Deoxy-2-[18F]-Fluoro-D-Glucose PET/CT in Patients With Locally Advanced Esophageal Cancer Undergoing Neoadjuvant Chemoradiotherapy Before Surgery: A Nonparametric Approach
por: Giorgetti, Assuero, et al.
Publicado: (2016)

Positron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16α-18F-fluoro-17β-estradiol PET
por: Yoshida, Yoshio, et al.
Publicado: (2009)

Positron emitting (18)F-2-deoxy-2-fluoro-D-glucose: potential hot new therapy
por: Mortimer, Joanne E, et al.
Publicado: (2003)

18F‐fluoro‐2‐deoxy‐2‐d‐glucose PET‐CT (FDG PET‐CT) in staging of high‐risk renal and urothelial bladder cancers (COPPER‐T) trial protocol
por: Jena, Rahul, et al.
Publicado: (2023)

Assessment of left and right ventricular functional parameters using dynamic dual-tracer [(13)N]NH3 and [(18)F]FDG PET/MRI
por: Rasul, Sazan, et al.
Publicado: (2020)

PET Imaging of Fructose Metabolism in a Rodent Model of Neuroinflammation with 6-[(18)F]fluoro-6-deoxy-D-fructose
por: Boyle, Amanda J., et al.
Publicado: (2022)

2-Deoxy-2-fluoro-d-glucose metabolism in Arabidopsis thaliana
por: Fatangare, Amol, et al.
Publicado: (2015)

Ferret Thoracic Anatomy by 2-Deoxy-2-(18F)Fluoro-D-Glucose (18F-FDG) Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) Imaging
por: Wu, Albert, et al.
Publicado: (2012)

Impact of ECG gating methods on the assessment of left ventricular cardiac function using PET/MRI
por: Rasul, Sazan, et al.
Publicado: (2022)

Summary of the Standards, Options and Recommendations for the use of positron emission tomography with 2-[(18)F]fluoro-2-deoxy-D-glucose (FDP-PET scanning) in oncology (2002)
por: Bourguet, P, et al.
Publicado: (2003)

2-deoxy-2[(18)F]fluoro-D-glucose positron emission tomography–computed tomography in rheumatological diseases
por: Subesinghe, Manil, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hg39cj7qa6q2hqs31dpg721jdo